O33 Duodenal-jejunal bypass liner therapy (Endobarrier®) causes reductions in plasma trimethylamine-N-oxide in obese patients with diabetes
Proceedings article published in 2021 by
Aruchuna Ruban,
Michael Glaysher,
Hutan Ashrafian,
Alex Miras 
,
Christina Prechtl,
Anthony Goldstone ,
Madhawi Aldhwayan,
Navpreet Chhina,
Werd Al-Najim,
Jia Li,
James Byrne,
Julian Teare
,
Christina Prechtl,
Anthony Goldstone ,
Madhawi Aldhwayan,
Navpreet Chhina,
Werd Al-Najim,
Jia Li,
James Byrne,
Julian Teare
